101 related articles for article (PubMed ID: 14627165)
1. Trichomonas vaginalis: determination of acid phosphatase activity as a pharmacological screening procedure.
Martínez-Grueiro MM; Montero-Pereira D; Giménez-Pardo C; Nogal-Ruiz JJ; Escario JA; Gómez-Barrio A
J Parasitol; 2003 Oct; 89(5):1076-7. PubMed ID: 14627165
[TBL] [Abstract][Full Text] [Related]
2. Biological assay of potential trichomonacides in vitro using a counter apparatus.
Brotherton J
Arzneimittelforschung; 1978; 28(10):1665-72. PubMed ID: 314804
[TBL] [Abstract][Full Text] [Related]
3. Alternative pathway of metronidazole activation in Trichomonas vaginalis hydrogenosomes.
Hrdý I; Cammack R; Stopka P; Kulda J; Tachezy J
Antimicrob Agents Chemother; 2005 Dec; 49(12):5033-6. PubMed ID: 16304169
[TBL] [Abstract][Full Text] [Related]
4. A new photometric assay with bromocresol purple for testing in vitro antitrichomonal activity in aerobic environment.
Loiseau PM; Bories C; Sanon A
Arzneimittelforschung; 1999 Jan; 49(1):51-5. PubMed ID: 10028380
[TBL] [Abstract][Full Text] [Related]
5. [In vitro effect of metronidazole ester on Trichomonas vaginalis and Entamoeba histolytica].
He Y; Tao X; Guan L; Lian W
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(1):32-4. PubMed ID: 7788891
[TBL] [Abstract][Full Text] [Related]
6. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput colorimetric and fluorometric microassay for the evaluation of nitroimidazole derivatives anti-trichomonas activity.
Campos Aldrete ME; Salgado-Zamora H; Luna J; Meléndez E; Meráz-Ríos MA
Toxicol In Vitro; 2005 Dec; 19(8):1045-50. PubMed ID: 15963680
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA
J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115
[TBL] [Abstract][Full Text] [Related]
9. Anti-Trichomonas vaginalis activity of synthetic lipophilic diamine and amino alcohol derivatives.
Giordani RB; De Almeida MV; Fernandes E; França da Costa C; De Carli GA; Tasca T; Zuanazzi JA
Biomed Pharmacother; 2009 Sep; 63(8):613-7. PubMed ID: 19013752
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
Petmitr PC; Ramdja M; Kajorndechakiat S
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
[TBL] [Abstract][Full Text] [Related]
11. [In vitro effect of secnidazole benzoate on Trichomonas vaginalis].
Zhang XX; Zheng SS; Zhu MM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Apr; 27(2):111-4. PubMed ID: 19856497
[TBL] [Abstract][Full Text] [Related]
12. Setting a colorimetric assay with MTT for assessment of trichomonicidal activity.
Sariego I; Monzote L; Rojas L
Curr Clin Pharmacol; 2014; 9(3):283-7. PubMed ID: 23173972
[TBL] [Abstract][Full Text] [Related]
13. A study on the in vitro susceptibility of Trichomonas vaginalis to metronidazole.
Lin PR; Shaio MF
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1994 Feb; 27(1):38-45. PubMed ID: 9747331
[TBL] [Abstract][Full Text] [Related]
14. [Antitrichomonal properties of derivatives of ethers containing amine and halogenarylalkyl groups].
Białasiewicz D; Kotełko B; Kurnatowska A; Kwaśniewska J
Wiad Parazytol; 1990; 36(5-6):281-5. PubMed ID: 2131703
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Cladonia alpestris on Trichomonas vaginalis in vitro].
Wu J; Zhang M; Ding D; Tan T; Yan B
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):126-9. PubMed ID: 7554162
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl-beta-D-hexosaminidase from Trichomonas vaginalis: substrate specificity and activity of inhibitors.
Sanon A; Tournaire-Arellano C; El Hage SY; Bories C; Caujolle R; Loiseau PM
Biomed Pharmacother; 2005 Jun; 59(5):245-8. PubMed ID: 15890491
[TBL] [Abstract][Full Text] [Related]
17. Protocols for the routine screening of drug sensitivity in the human parasite Trichomonas vaginalis.
Natto MJ; Eze AA; de Koning HP
Methods Mol Biol; 2015; 1263():103-10. PubMed ID: 25618339
[TBL] [Abstract][Full Text] [Related]
18. [Effect of tinidazole on T. vaginalis in vitro].
Savoia D; Martinetto P; Pugliese A
G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):32-8. PubMed ID: 4134002
[No Abstract] [Full Text] [Related]
19. Activities of dicationic compounds against Trichomonas vaginalis.
Crowell AL; Stephens CE; Kumar A; Boykin DW; Secor WE
Antimicrob Agents Chemother; 2004 Sep; 48(9):3602-5. PubMed ID: 15328138
[TBL] [Abstract][Full Text] [Related]
20. [Trichomonacidal activity of newly synthesized derivatives of benzoizothiazolinon (BIT) in vitro].
Ziomko I; Kuczyńska E
Wiad Parazytol; 1994; 40(1):59-64. PubMed ID: 8023507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
